Renaissance Technologies - ANGION BIOMEDICA CORP ownership

ANGION BIOMEDICA CORP's ticker is ANGN and the CUSIP is 03476J107. A total of 39 filers reported holding ANGION BIOMEDICA CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ANGION BIOMEDICA CORP
ValueSharesWeighting
Q1 2023$54
-45.5%
93,015
-23.6%
0.00%
Q4 2022$99
-99.9%
121,700
-41.8%
0.00%
Q3 2022$192,000
-21.0%
208,977
-2.1%
0.00%
Q2 2022$243,000
-48.7%
213,500
-4.6%
0.00%
-100.0%
Q1 2022$474,000
-14.4%
223,700
+17.1%
0.00%0.0%
Q4 2021$554,000191,1000.00%
Other shareholders
ANGION BIOMEDICA CORP shareholders Q3 2022
NameSharesValueWeighting ↓
CM Management, LLC 525,000$599,0000.64%
Nantahala Capital Management 1,131,001$1,289,0000.06%
BVF INC/IL 1,071,297$1,221,0000.06%
Birchview Capital, LP 54,392$62,0000.04%
Knoll Capital Management, LLC 60,000$68,0000.04%
Ground Swell Capital, LLC 16,258$19,0000.04%
LAKE STREET ADVISORS GROUP, LLC 246,904$282,0000.02%
Patriot Financial Group Insurance Agency, LLC 36,500$41,0000.01%
BLB&B Advisors, LLC 56,847$65,0000.01%
Park West Asset Management LLC 75,503$86,0000.01%
View complete list of ANGION BIOMEDICA CORP shareholders